about
Prevalence of diabetic retinopathy in Tehran province: a population-based studyThe Association of Central Corneal Thickness with Ocular and General Parameters in a Community Setting: The Yazd Eye Study.Perioperative prophylaxis for endophthalmitis after cataract surgery in iran"Planning eye health services in Varamin district, Iran: a cross-sectional study".Causes of visual impairment among patients referred to a visual rehabilitation clinic in Iran.Prevalence and Causes of Visual Impairment and Blindness in Central Iran; The Yazd Eye Study.Prevalence of second-eye cataract surgery and time interval after first-eye surgery in Iran: a clinic-based studyAwareness of the Necessity of Regular Eye Examinations among Diabetics: The Yazd Eye Study.Profile of cataract surgery in Varamin Iran: a population-based study.Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy in Gilan Province, Iran.Distribution of intraocular pressure, central corneal thickness and vertical cup-to-disc ratio in a healthy Iranian population: the Yazd Eye Study.The Impact of Congenital Strabismus Surgery on Quality of Life in Children.Prevalence and Risk Factors for Trachoma in Rural Areas of Sistan-va-Baluchestan Province, Iran: A Population-Based Study.A population-based survey of the prevalence and types of glaucoma in central Iran: the Yazd eye study.Epidemiology of keratoconus in an Iranian population.Modeling a Telemedicine Screening Program for Diabetic Retinopathy in Iran and Implementing a Pilot Project in Tehran SuburbRapid Assessment of Avoidable Blindness in Kurdistan, IranDesigning a Screening Program for Prevention of Avoidable Blindness in Iran through a Participatory Action ApproachAssociation between acute corneal hydrops in patients with keratoconus and mitral valve prolapseRapid assessment of avoidable blindness in IranPrevalence and risk factors for diabetic retinopathy in the 40 to 80 year-old population in Yazd, Iran: the Yazd Eye StudyEye Care Utilization in A Community-oriented Mobile Screening Programme for Improving Eye Health in Iran: A Cluster Randomized Trial
P50
Q33511025-13DBF698-1093-4805-8B87-DC87368C5E8AQ33652586-4B3183E1-3DB7-4642-BDA4-A513EE2D8496Q35584470-426BB3D3-C2C1-476F-B31F-2D39C1379E5CQ35645459-DB75AECC-EFEF-4B90-8153-7BB210F72C2FQ35886980-B6B944A5-C418-4AF5-A44F-E1A22D395294Q36393608-BEE5F779-E320-42AB-9D61-F32CD06FF74BQ36743054-90F92FD5-B3ED-4BE5-B998-A902B978533EQ40101960-94F30966-8C03-4837-B7DA-2B35D81B83ABQ40129695-56A275F0-6D41-4875-A917-D02F2CD6C492Q40236909-985EBF6D-CD9B-440F-815A-A2964DC85076Q40517401-30F4A781-74DF-45B6-A04A-BDA07D1ACBD5Q40652153-5C124085-B7E9-4DBF-A318-91EB6F2C6E5AQ40754480-D15026E8-ADDB-4183-A2D1-20372AB57A35Q46544921-3B644E07-1A4B-492A-9142-D656AF778F22Q51186828-414C1B2D-C811-47E4-9D88-7150B64F2E1BQ64068577-D559668E-52BC-417A-B819-856ADF0FA18AQ64095270-9B9346A6-02B9-42FA-8E4A-D6DDF6FACAB0Q64227523-6A54AD36-212D-41E8-9F42-99575F051D1CQ82285294-15A40103-2349-4BF4-ACDA-4523882A9725Q84100553-11770F22-1569-4766-A097-2566AC901B4CQ87600950-02923D3B-32F7-44F7-92E9-107111D20CFCQ95657862-E59DED7A-0668-42A6-A112-39931463E302
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marzieh Katibeh
@ast
Marzieh Katibeh
@en
Marzieh Katibeh
@es
Marzieh Katibeh
@nl
Marzieh Katibeh
@sl
type
label
Marzieh Katibeh
@ast
Marzieh Katibeh
@en
Marzieh Katibeh
@es
Marzieh Katibeh
@nl
Marzieh Katibeh
@sl
prefLabel
Marzieh Katibeh
@ast
Marzieh Katibeh
@en
Marzieh Katibeh
@es
Marzieh Katibeh
@nl
Marzieh Katibeh
@sl
P106
P1153
26326317100
P31
P496
0000-0002-1542-7117